https://pienomial.com/clinical-trial-intelligen/4b-technologies-announces-positive-phase-1-results-for-novel-non-opioid-chronic-pain-therapy 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/4teen4-announces-promising-first-in-human-data-for-procizumab-in-cardiogenic-shock 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ab-science-announces-initial-phase-1-data-for-ab8939-and-venetoclax-combination-in-refractory-or-relapsed-acute-myeloid-leukemia 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/abbotts-freestyle-libre-cgm-reduces-cardiovascular-hospitalizations-in-people-with-diabetes 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/abbvie-announces-positive-phase-3-results-for-upadacitinib-rinvoq-in-vitiligo 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/abbvies-verona-trial-for-higher-risk-myelodysplastic-syndromes-misses-primary-endpoint 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/abcellera-announces-positive-preclinical-data-for-abcl575-an-anti-ox40l-antibody-for-atopic-dermatitis 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/abivax-announces-positive-phase-3-results-for-obefazimod-in-ulcerative-colitis 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/abivax-announces-positive-results-from-abtect-induction-trials-of-obefazimod-in-ulcerative-colitis-patients 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/actuate-therapeutics-announces-positive-phase-2-elraglusib-data-in-metastatic-pancreatic-cancer 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/actuate-therapeutics-elraglusib-shows-promising-results-in-metastatic-pancreatic-cancer 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/adagene-announces-positive-updated-data-for-muzastotug-adg126-in-combination-with-pembrolizumab-for-colorectal-cancer-at-asco 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/aicuris-pritelivir-meets-primary-endpoint-in-phase-3-trial-for-refractory-herpes-simplex-virus-in-immunocompromised-patients 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/airiver-medical-receives-fda-ide-approval-for-pivotal-clinical-study-of-airiver-pulmonary-drug-coated-balloon 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/akebia-initiates-post-marketing-study-for-vafseo-vadadustat-in-ckd-anemia 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/al-s-pharma-announces-positive-phase-2-results-for-ap-101-in-als-treatment 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/alafair-biosciences-initiates-multi-center-study-on-versawrap-for-achilles-tendon-repair 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/aldeyra-therapeutics-receives-fda-special-protocol-assessment-for-adx-2191-in-primary-vitreoretinal-lymphoma 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/alligator-bioscience-presents-positive-biomarker-data-for-mitazalimab-in-pancreatic-cancer-at-asco-2025 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/alnylam-to-advance-zilebesiran-into-global-phase-3-cardiovascular-outcomes-trial 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/alphamedix-phase-2-data-shows-potential-in-gastroenteropancreatic-neuroendocrine-tumors 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/alterity-therapeutics-reports-positive-phase-2-data-for-ath434-in-multiple-system-atrophy 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/alto-neuroscience-validates-eeg-biomarker-for-schizophrenia-strengthening-phase-2-trial-of-alto-101 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/amgens-repatha-phase-3-vesalius-cv-trial-data-to-be-presented-at-aha-2025 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/anaptys-announces-positive-phase-2b-results-for-rosnilimab-in-rheumatoid-arthritis 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ani-pharmaceuticals-announces-new-day-clinical-trial-results-for-iluvien-in-diabetic-macular-edema 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/anika-therapeutics-announces-topline-results-from-hyalofast-phase-iii-cartilage-repair-study 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/apnimed-presents-phase-3-data-for-ad109-in-obstructive-sleep-apnea-at-chest-2025 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/applied-therapeutics-to-present-updated-data-on-govorestat-at-pns-2025-meeting 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/artelo-biosciences-announces-positive-first-in-human-data-for-art2612-a-novel-non-opioid-pain-treatment 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ascentage-pharmas-lisaftoclax-shows-promise-in-venetoclax-refractory-patients-asco-2025-presentation 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ascletis-initiates-phase-iia-trial-of-oral-glp-1r-agonist-asc30-for-obesity 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ascletis-to-present-asc30-data-at-easd-annual-meeting 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/askbio-announces-positive-12-month-data-from-phase-1-trial-of-ab-1002-gene-therapy-for-congestive-heart-failure-in-nature-medicine 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/aspen-neuroscience-announces-positive-6-month-results-for-parkinsons-disease-cell-therapy 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/aspire-biopharma-announces-positive-final-results-for-sublingual-aspirin-in-treating-heart-attacks 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/astria-therapeutics-to-present-navenibart-data-at-c1-inhibitor-deficiency-and-angioedema-workshop 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/atossa-therapeutics-receives-positive-fda-feedback-for-z-endoxifen-in-metastatic-breast-cancer 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/atossa-therapeutics-seeks-accelerated-approval-for-low-dose-z-endoxifen-for-breast-cancer-risk-reduction 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/autobahn-therapeutics-presents-positive-phase-1-results-for-abx-002-at-ascp-annual-meeting 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/avalyn-pharma-presents-positive-clinical-data-for-inhaled-pulmonary-fibrosis-treatments-at-ats-2025 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/avant-technologies-and-ainnova-complete-pivotal-fda-meeting-for-vision-ai-diabetic-retinopathy-platform 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/avant-technologies-and-ainnova-tech-enhance-patient-recruitment-for-diabetic-retinopathy-ai-platform-clinical-trial 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/avidicure-to-present-preclinical-data-on-trop2-targeting-antibody-at-asco-2025 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/baxdrostat-shows-significant-blood-pressure-reduction-in-phase-iii-hypertension-trial 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/be-biopharma-announces-preclinical-data-for-be-102-in-hypophosphatasia 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/bicara-therapeutics-announces-positive-interim-data-for-ficerafusp-alfa-in-head-and-neck-cancer 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/bicycle-therapeutics-announces-positive-clinical-trial-results-for-zelenectide-pevedotin-at-asco-2025 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/bimzelx-bimekizumab-shows-lasting-efficacy-in-psoriatic-arthritis-and-axial-spondyloarthritis-after-three-years 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/biodesix-to-present-veristrat-test-data-at-asco-2025 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/bioinvent-announces-positive-phase-1-data-for-bi-1206-in-combination-with-pembrolizumab-in-solid-tumors 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/boehringer-and-click-therapeutics-present-positive-phase-iii-data-for-ct-155-in-schizophrenia 2026-04-06T14:24:08.383Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/boehringer-ingelheim-to-present-early-clinical-data-on-sirp-inhibitors-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/boehringer-ingelheim-to-present-early-clinical-data-on-sirp-inhibitors-at-asco-2025-1bb72 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/bolt-biotherapeutics-presents-preclinical-data-on-next-generation-boltbody-isacs 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/bolt-biotherapeutics-updates-on-bdc-4182-and-extends-cash-runway-into-2027 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/breath-diagnostics-onebreath-technology-predicts-pneumonia-onset-through-exhaled-breath-analysis 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/breathe-biomedical-expands-multi-center-breast-cancer-breath-test-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/briacells-phase-2-trial-shows-promising-survival-rates-in-metastatic-breast-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/bristol-myers-squibb-to-present-oncology-data-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/bryet-us-receives-approval-to-initiate-phase-12-trial-of-ml-016-in-advanced-cancers-with-lung-andor-liver-involvement-in-australia 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/candel-therapeutics-to-present-can-2409-data-at-sitc-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/cantargias-can10-shows-promise-in-inhibiting-vascular-inflammation 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/caris-assure-blood-based-assay-shows-promise-for-multi-cancer-early-detection-and-monitoring 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/casi-pharmaceuticals-announces-dose-escalation-in-phase-1-cid-103-itp-study 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/cassava-sciences-reports-positive-preclinical-study-of-simufilam-for-tsc-related-epilepsy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/catalym-presents-positive-long-term-phase-12a-data-for-visugromab-in-cpi-refractory-tumors-at-esmo-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/celecor-therapeutics-announces-positive-phase-3-results-for-disaggpro-in-heart-attack-patients 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/cerevance-to-present-phase-1-data-on-cvn293-a-kcnk13-inhibitor-at-aaic-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/cizzle-bio-submits-nih-grant-for-lung-cancer-biomarker-blood-test 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/clene-presents-preclinical-data-supporting-cnm-au8-for-parkinsons-disease 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/clene-provides-regulatory-update-on-cnm-au8-for-als-and-ms 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/columvi-extends-overall-survival-in-relapsedrefractory-dlbcl-patients-two-year-follow-up-data 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/compass-pathways-announces-positive-phase-2-results-for-comp360-psilocybin-in-ptsd 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/compass-pathways-comp360-psilocybin-shows-positive-phase-3-results-for-treatment-resistant-depression 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/coya-therapeutics-announces-fda-acceptance-of-ind-for-coya-302-to-treat-als 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/cullinan-therapeutics-presents-preclinical-data-for-cln-978-supporting-clinical-development-in-autoimmune-diseases-at-acr-convergence-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/curegenes-cg-0416-shows-promise-as-dual-action-therapy-for-obesity-and-mash 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/cytosorbents-therapy-reduces-bleeding-in-urgent-cabg-patients-on-ticagrelor 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/daewoong-pharmaceuticals-bersiporocin-receives-positive-idmc-safety-review-in-phase-2-ipf-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/daiichi-sankyo-presents-practice-changing-enhertu-data-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/danish-study-finds-no-link-between-aluminum-in-vaccines-and-50-health-conditions 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/darnatein-to-present-advances-in-regenerative-biologics-at-bmp-conference 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/datroway-improves-overall-and-progression-free-survival-in-metastatic-triple-negative-breast-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/dbv-technologies-begins-phase-3-safety-study-for-viaskin-peanut-patch-in-peanut-allergic-toddlers 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/decisiondx-melanoma-test-outperforms-existing-methods-in-identifying-low-risk-melanoma-patients 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/diakonos-oncology-initiates-phase-2-trial-of-doc1021-for-glioblastoma 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/disc-medicine-to-present-phase-1b-data-of-disc-0974-in-ckd-patients-with-anemia-at-asn-kidney-week-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/edgewise-therapeutics-announces-positive-sevasemten-results-for-becker-and-duchenne-muscular-dystrophy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/editas-medicine-announces-edit-401-oral-presentation-at-esgct-congress-and-participation-in-investor-conferences 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/eg-427-announces-positive-topline-results-for-eg110a-in-neurogenic-bladder-patients 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/emd-serono-presents-oncology-data-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/encoded-therapeutics-announces-positive-preclinical-data-for-non-opioid-gene-therapy-candidate-for-chronic-pain 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/endogenex-presents-positive-48-week-regent-1-clinical-trial-results-for-type-2-diabetes-treatment 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/enterra-medical-initiates-navigate-study-for-gastric-electrical-stimulation-ges-in-chronic-nausea 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/envoy-medicals-pivotal-trial-for-acclaim-cochlear-implant-shows-positive-one-month-follow-up-results 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/exact-sciences-highlights-cancer-detection-innovations-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/exelixis-announces-positive-phase-3-results-for-zanzalintinib-and-atezolizumab-combination-in-metastatic-colorectal-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/exelixis-presents-encouraging-zanzalintinib-combination-therapy-results-for-advanced-kidney-cancer-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/eyepoint-completes-enrollment-of-pivotal-phase-3-trials-for-duravyu-in-wet-amd 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/first-ever-combined-implantation-of-motus-device-and-tops-system-for-lumbar-spinal-degeneration 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/first-participant-dosed-in-act-early-a-primary-prevention-study-for-transthyretin-amyloid-cardiomyopathy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/foghorn-therapeutics-announces-updates-for-selective-arid1b-cbp-and-ep300-degrader-programs 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/fulcrum-therapeutics-announces-positive-phase-1b-results-for-pociredir-in-sickle-cell-disease 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/gain-therapeutics-receives-approval-for-phase-1b-dosing-extension-of-gt-02287-for-parkinsons-disease 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/genedxs-seqfirst-study-shows-rapid-genomic-testing-significantly-improves-pediatric-diagnosis 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/genentechs-gazyva-shows-positive-phase-iii-data-with-significant-reduction-in-disease-activity-for-systemic-lupus-erythematosus 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/genesight-test-shows-faster-remission-and-response-in-depression-treatment-post-hoc-analysis 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/genmab-to-present-late-stage-oncology-data-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/genocury-biotechs-in-vivo-cd19-car-t-therapy-shows-promise-in-relapsedrefractory-dlbcl 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/gh-research-announces-global-pivotal-program-plans-for-gh001-and-gh002 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/gilead-and-kite-present-new-cancer-data-at-esmo-2025-highlighting-trodelvys-potential-in-metastatic-tnbc 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/glytr-therapeutics-announces-publication-of-pan-cancer-immunotherapy-platform-study-in-cell 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/guardant-health-to-present-liquid-biopsy-data-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/harmony-biosciences-presents-preclinical-data-for-bp115205-a-potential-best-in-class-ox2r-agonist-for-narcolepsy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/hemogenyx-pharmaceuticals-expands-pediatric-rr-aml-trial-for-hg-ct-1-car-t-therapy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/hengrui-and-kailera-present-clinical-data-for-hrs9531-and-hrs-7535-at-ada-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/hologic-presents-new-data-on-breast-cancer-index-test-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/hutchmed-to-present-clinical-data-at-2025-asco-annual-meeting 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/hydronidone-shows-significant-fibrosis-regression-in-phase-3-trial-for-chb-associated-liver-fibrosis 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ideaya-biosciences-announces-10-year-anniversary-rd-day 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ideaya-biosciences-announces-agenda-for-10-year-anniversary-rd-day 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ideaya-biosciences-announces-positive-phase-2-data-for-darovasertib-in-neoadjuvant-primary-uveal-melanoma 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ideaya-biosciences-announces-positive-phase-2-data-for-darovasertib-in-uveal-melanoma 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/imcheck-reports-high-remission-rates-in-aml-patients-with-ict01-combination-therapy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/imdx-enrolls-first-patient-in-graftassuredx-clinical-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/immix-biopharmas-nxc-201-shows-promising-results-for-relapsedrefractory-al-amyloidosis 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/immuneering-and-lilly-partner-to-evaluate-atebimetinib-and-olomorasib-in-phase-2-nsclc-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/immunic-reports-positive-long-term-data-for-vidofludimus-calcium-in-ms 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/impact-biotech-to-present-enlighted-study-interim-analysis-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/improved-cardiac-surgery-outcomes-with-active-chest-tube-clearance 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/imvaria-presents-multi-site-clinical-data-on-ai-diagnostic-service-for-idiopathic-pulmonary-fibrosis-at-ats-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/indivior-advances-addexs-gabab-pam-program-through-ind-enabling-studies 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/indivior-presents-data-on-sublocade-for-opioid-use-disorder-in-high-fentanyl-users 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/innate-pharmas-abstracts-selected-for-asco-2025-annual-meeting 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/innovents-mazdutide-demonstrates-superior-glycemic-control-and-weight-loss-compared-to-semaglutide-in-phase-3-dreams-3-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/invivyd-announces-us-ind-clearance-and-fda-alignment-for-vyd2311-covid-prevention-program 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/itf-therapeutics-announces-positive-long-term-givinostat-data-for-duchenne-muscular-dystrophy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/itm-to-present-compete-trial-data-at-snmmi-2025-annual-meeting 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/jedicare-medical-announces-successful-first-in-human-study-of-novel-pulmonary-nodule-removal-device 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/kala-bio-completes-enrollment-in-chase-trial-for-kpi-012-in-persistent-corneal-epithelial-defect 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/kalvista-pharmaceuticals-presents-positive-data-on-sebetralstat-for-on-demand-hae-treatment 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/kazia-therapeutics-announces-preclinical-data-on-paxalisib-for-triple-negative-breast-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/kelun-biotech-presents-positive-clinical-trial-data-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/keros-therapeutics-initiates-phase-3-trial-of-elritercept-for-mds 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/klotho-neurosciences-advances-manufacturing-of-als-gene-therapy-klto-202 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/kyverna-therapeutics-announces-conference-call-on-interim-phase-2-data-of-kyv-101-in-generalized-myasthenia-gravis 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/kyverna-therapeutics-announces-positive-phase-2-interim-data-for-kyv-101-in-generalized-myasthenia-gravis 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/largest-ever-sickle-cell-disease-study-completed-paving-way-for-new-treatments 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/legend-biotech-presents-new-data-on-carvykti-and-pipeline-candidates-at-asco-eha-and-asgct 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/lift-biosciences-presents-preclinical-data-on-immunomodulatory-alpha-neutrophils-imans-for-solid-tumors 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/lilly-announces-asco-2025-presentations-on-oncology-pipeline 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/lillys-jaypirca-pirtobrutinib-meets-primary-endpoint-in-phase-3-cllsll-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/lillys-omvoh-mirikizumab-mrkz-shows-improvement-in-bowel-urgency-for-ulcerative-colitis-patients 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/lillys-oral-glp-1-agonist-orforglipron-shows-significant-weight-loss-in-phase-3-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/linvoseltamab-combination-therapy-shows-promising-results-in-multiple-myeloma 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/lisata-therapeutics-announces-positive-preliminary-results-from-cendifox-trial-in-pancreatic-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/lyell-immunopharma-announces-positive-clinical-data-for-lyl314-in-large-b-cell-lymphoma 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/maplight-therapeutics-initiates-phase-2-trial-for-ml-007c-ma-in-schizophrenia 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/marker-therapeutics-announces-first-patient-treated-in-off-the-shelf-program-for-aml-and-mds 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/masimo-sedline-improves-pediatric-anesthesia-outcomes 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/meco-score-a-novel-biomarker-for-predicting-response-to-antifibrotic-therapy-in-breast-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/mediview-launches-multicenter-study-for-xr90-surgical-navigation-system-in-soft-tissue-biopsy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/merck-to-present-oncology-research-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/mercks-enlicitide-decanoate-meets-primary-endpoints-in-phase-3-hypercholesterolemia-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/mercks-verquvo-vericiguat-shows-mixed-results-in-chronic-heart-failure-trials 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/merus-bispecific-antibody-shows-promising-results-in-head-and-neck-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/microglia-replacement-shows-promise-in-treating-leukodystrophies 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/mink-therapeutics-announces-complete-remission-in-metastatic-testicular-cancer-using-inkt-cell-therapy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/mira-pharmaceuticals-completes-phase-1-trial-of-oral-ketamir-2-for-neuropathic-pain 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/miradxs-microrna-based-platform-predicts-cancer-treatment-outcomes 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/moderna-announces-data-presentation-at-esmo-congress-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/moderna-announces-positive-phase-3-results-for-seasonal-influenza-vaccine 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/modernas-phase-3-cmv-vaccine-trial-fails-to-meet-primary-efficacy-endpoint 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/moleculight-imaging-improves-deep-sternal-wound-infection-outcomes-and-reduces-costs-in-taiwan-study 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/monteris-medical-announces-positive-jama-neurology-publication-on-neuroblate-system-for-epilepsy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/myrtelle-announces-encouraging-interim-results-from-phase-12-gene-therapy-trial-for-canavan-disease 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/mythic-therapeutics-presents-positive-phase-1-data-for-mytx-011-in-nsclc 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/nadunolimab-plus-pembrolizumab-shows-potential-in-solid-tumors 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/napo-pharmaceuticals-to-meet-with-fda-regarding-crofelemer-for-ultrarare-pediatric-mvid 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/nervgen-announces-leadership-transition-and-positive-chronic-spinal-cord-injury-trial-results-for-nvg-291 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/neurocrine-biosciences-initiates-phase-3-trial-for-nbi-1117568-in-schizophrenia 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/neurocrine-biosciences-presents-cahtalog-registry-analysis-at-endo-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/neurostar-tms-shows-efficacy-in-treating-depression-in-adolescents-and-young-adults 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/neuvivo-secures-fda-alignment-for-np001-als-treatment-and-appoints-dr-john-curnutte-to-board 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/novartis-presents-promising-oncology-and-hematology-data-at-asco-and-eha 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/novo-nordisk-advances-amycretin-an-obesity-medication-to-phase-3-clinical-development 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/novo-nordisk-advances-amycretin-for-weight-management-to-phase-3 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/novo-nordisk-to-present-new-data-on-semaglutide-cagrisema-and-amycretin-at-ada-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/nutshell-therapeutics-receives-fda-clearance-for-phase-1-trial-of-nts071 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/nuvectis-pharma-announces-upcoming-presentations-for-nxp900-at-aacr-nci-eortc-conference 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/obi-pharmas-obi-902-ind-application-cleared-for-phase-12-trial-in-advanced-solid-tumors 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ocugen-announces-fda-clearance-for-phase-23-trial-of-ocu410st-for-stargardt-disease 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ocugen-announces-positive-ema-scientific-advice-for-ocu410st-gene-therapy-for-stargardt-disease 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ocugen-initiates-phase-23-trial-for-stargardt-disease-gene-therapy 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/okyo-pharmas-urcosimod-shows-promising-phase-2-results-for-neuropathic-corneal-pain 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/olema-oncology-announces-positive-phase-1b2-data-of-palazestrant-plus-ribociclib-in-erher2--metastatic-breast-cancer-at-esmo-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/olezarsen-shows-significant-reduction-in-triglycerides-and-acute-pancreatitis-in-shtg-patients 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/oncare-alliance-and-exigent-research-launch-outpatient-bispecifics-cancer-treatment-program 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/oncolytics-biotech-highlights-pelareorep-efficacy-in-metastatic-colorectal-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/oncotelic-therapeutics-announces-publication-showing-tgfb2-methylation-as-positive-prognostic-marker-in-pancreatic-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/onward-medical-achieves-fifth-successful-brain-computer-interface-implant 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/onward-medical-announces-positive-results-for-arc-im-therapy-in-blood-pressure-regulation-after-spinal-cord-injury 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/oragenics-announces-us-manufacturing-agreement-for-onp-002-concussion-treatment 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/oruka-therapeutics-announces-ind-clearance-for-phase-2a-trial-of-orka-001-in-psoriasis 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/os-therapies-announces-positive-phase-2b-data-for-ost-her2-in-osteosarcoma 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/os-therapies-announces-positive-survival-data-for-ost-her2-in-metastatic-osteosarcoma-subgroups 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/os-therapies-to-present-at-biofuture-2025-and-discuss-ost-her2-clinical-development 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/palatin-announces-positive-preclinical-data-for-oral-mc4r-agonist-pl7737-in-obesity 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/palvella-therapeutics-announces-publication-on-rapamycin-for-venous-malformations 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/personalis-next-personal-mrd-test-shows-superiority-in-neoadjuvant-lung-cancer-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/petosemtamab-plus-pembrolizumab-shows-strong-efficacy-in-head-and-neck-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/pfizer-to-present-phase-1-data-on-mesoc2-adc-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/plus-therapeutics-announces-initial-patient-treatment-in-reyobiq-leptomeningeal-metastases-dose-optimization-trial 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/positive-phase-1-data-for-ide849-shr-4849-in-small-cell-lung-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/positive-phase-12-data-for-ide397-and-trodelvy-combination-in-mtap-deletion-urothelial-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/positive-phase-1b-results-for-tx45-in-group-2-pulmonary-hypertension 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/positive-phase-ii-results-for-carsgens-satri-cel-in-advanced-gastric-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/positive-updated-results-for-avutometinib-plus-defactinib-in-frontline-metastatic-pancreatic-cancer 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/poxel-sa-highlights-imeglimins-potential-at-ada-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/praxis-announces-positive-phase-3-results-for-ulixacaltamide-in-essential-tremor 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/praxis-precision-medicines-announces-positive-phase-2-results-for-vormatrigine-in-focal-onset-seizures 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/prilenia-and-ferrer-announce-phase-3-als-study-of-pridopidine-at-neals-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/promising-antileukemic-activity-of-bleximenib-in-combination-therapy-for-acute-myeloid-leukemia 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/protagonist-announces-clinical-data-presentations-for-icotrokinra-and-pn-881-at-eadv-2025-congress 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/qlaris-bio-to-present-new-data-on-qls-111-for-glaucoma-at-world-glaucoma-congress 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/rakuten-medical-announces-phase-3-trial-progress-for-asp-1929-photoimmunotherapy-at-asco-2025 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/rapport-therapeutics-to-announce-topline-phase-2a-results-for-rap-219-in-focal-onset-seizures 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/regenerons-positive-phase-3-allergy-trials-advance-first-in-class-antibody-blockers 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/renovaros-genetically-engineered-dendritic-cell-therapy-shows-potent-anti-tumor-efficacy-in-preclinical-study 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/research-advances-from-the-2025-alzheimers-association-international-conference 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/roche-and-alnylam-advance-zilebesiran-into-phase-iii-cardiovascular-outcomes-trial-for-uncontrolled-hypertension 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/rocket-pharmaceuticals-phase-2-danon-disease-trial-resumes-after-fda-lifts-clinical-hold 2026-04-06T14:24:08.384Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/rozanolixizumab-prevents-congenital-heart-block-recurrence-in-high-risk-pregnancy 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/rwjbarnabas-health-and-rutgers-cancer-institute-to-present-cancer-research-at-asco-2025 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/rybrevant-and-lazcluze-combination-prevents-acquired-resistance-in-first-line-egfr-mutated-nsclc 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/sanofis-amlitelimab-shows-promise-in-phase-3-atopic-dermatitis-study 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/schrdinger-reports-encouraging-phase-1-data-for-sgr-1505-in-relapsedrefractory-b-cell-malignancies 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/scynexis-presents-data-on-second-generation-antifungal-scy-247-at-timm-12 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/sellas-life-sciences-initiates-pediatric-aml-patient-dosing-in-phase-2-sls009-trial 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/serina-therapeutics-advances-poz-vmat2i-for-tardive-dyskinesia 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/servier-to-present-updates-on-idh-mutated-cancer-research-at-asco-2025 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/silexion-therapeutics-announces-positive-preclinical-results-for-sil204-in-lung-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/sionna-therapeutics-announces-phase-1-data-for-sion-719-and-sion-451-and-preclinical-data-on-nbd1-stabilizers-in-cystic-fibrosis 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/sionna-therapeutics-initiates-phase-2a-trial-of-sion-719-for-cystic-fibrosis 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/skyhawk-therapeutics-announces-positive-interim-phase-1-results-for-sky-0515-in-huntingtons-disease 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/soleno-therapeutics-announces-presentations-on-diazoxide-choline-for-prader-willi-syndrome-at-international-conference 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/soleno-therapeutics-announces-presentations-on-vykat-xr-for-prader-willi-syndrome-at-endo-2025 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/soleno-therapeutics-announces-presentations-on-vykat-xr-for-prader-willi-syndrome-at-pes-2025 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/spago-nanomedical-announces-positive-data-and-dose-increase-recommendation-for-177lu-sn201-in-phase-iiia-tumorad-01-study 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/spectral-medicals-tigris-trial-shows-positive-results-for-pmx-in-endotoxic-septic-shock 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/spyre-therapeutics-announces-positive-phase-1-results-for-anti-tl1a-antibody-programs-and-phase-2-clinical-development-plans 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/spyre-therapeutics-to-report-phase-1-interim-results-for-spy002-anti-tl1a-antibody 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/systimmune-and-bristol-myers-squibb-announce-phase-i-results-of-iza-bren-egfr-x-her3-adc-in-advanced-solid-tumors 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/systimmune-to-present-izalontamab-brengitecan-iza-bren-data-at-asco-2025 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/taiho-oncology-presents-positive-data-at-asco-2025-annual-meeting 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/takedas-oveporexton-shows-positive-phase-3-results-for-narcolepsy-type-1 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/taugen-files-patent-application-for-novel-tbi-drug-candidates 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/taysha-gene-therapies-presents-new-data-on-tsha-102-for-rett-syndrome-at-cns-annual-meeting 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/telomir-1-a-novel-epigenetic-therapy-targeting-dna-methylation-pathways 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/telomir-pharmaceuticals-telomir-1-shows-promise-in-preventing-cellular-aging-in-progeria 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/tenaya-therapeutics-receives-positive-safety-reviews-for-tn-201-and-tn-401-gene-therapy-trials 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/test-item 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/tevogen-updates-development-of-ai-powered-ebv-specific-t-cell-therapy 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/tg-therapeutics-completes-enrollment-in-phase-3-enhance-trial-of-simplified-dosing-for-briumvi-in-multiple-sclerosis 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/tiziana-life-sciences-announces-promising-immunologic-findings-of-nasal-foralumab-in-alzheimers-disease 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/tiziana-life-sciences-highlights-intranasal-foralumab-for-moderate-alzheimers-disease 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/tourmaline-bio-presents-positive-phase-2-data-for-pacibekitug-at-esc-congress-2025 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/travere-therapeutics-to-present-new-filspari-sparsentan-data-at-the-15th-international-podocyte-conference 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ucb-presents-thymidine-kinase-2-deficiency-tk2d-research-at-umdf-2025-conference 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/updated-elacestrant-data-highlights-combinability-in-metastatic-breast-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/urogens-zusduri-shows-long-term-efficacy-in-non-muscle-invasive-bladder-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/valitor-presents-preclinical-data-on-vltr-559-for-wet-amd 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/vaxarts-second-generation-norovirus-vaccine-shows-significantly-increased-antibody-responses-in-phase-1-trial 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/vergent-biosciences-abenacianine-improves-lung-cancer-tumor-visualization-in-phase-2b-trial 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/vial-initiates-phase-1-trial-of-subcutaneous-half-life-extended-anti-tl1a-antibody-for-ibd 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/vistagen-to-present-research-on-itruvone-and-fasedienol-at-ascp-conference 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/vor-bio-announces-positive-phase-3-results-of-telitacicept-in-systemic-lupus-erythematosus-published-in-nejm 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/voyager-therapeutics-announces-publication-demonstrating-novel-aav-capsid-for-blood-brain-barrier-transport 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/voyager-therapeutics-expands-alzheimers-disease-pipeline-with-novel-apoe-gene-therapy-program 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/vyne-therapeutics-phase-2b-repibresib-gel-trial-for-vitiligo-misses-primary-endpoint 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/wave-life-sciences-announces-positive-target-engagement-data-from-inlight-clinical-trial-of-wve-007-for-obesity 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/xencor-presents-phase-1-data-for-xmab819-in-clear-cell-renal-cell-carcinoma 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/xenetic-biosciences-expands-collaboration-to-advance-dnase-based-oncology-platform 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/xtandi-shows-long-term-overall-survival-benefit-in-metastatic-hormone-sensitive-prostate-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/zevra-therapeutics-to-present-multiple-datasets-on-miplyffa-arimoclomol-at-iciem 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/ziftomenib-shows-promise-in-treating-relapsedrefractory-npm1-mutant-aml 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/zivo-bioscience-announces-positive-results-in-avian-influenza-study 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/zomedica-launches-equine-asthma-clinical-registry-using-pulsevet-shock-wave-therapy 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/zymeworks-discontinues-zw171-clinical-development 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/zymeworks-presents-preclinical-data-for-zw1528-a-novel-bispecific-antibody-for-respiratory-inflammation 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-intelligen/zyversa-therapeutics-highlights-data-on-kidney-lipotoxicity-in-diabetic-kidney-disease 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/abbotts-navitor-tavi-system-receives-ce-mark-for-expanded-aortic-stenosis-indication 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/abbvie-seeks-fda-approval-for-venetoclax-and-acalabrutinib-combination-in-untreated-cll 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/aeon-biopharma-announces-fda-bpd-type-2a-meeting-for-abp-450 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/agios-pharmaceuticals-announces-pdufa-date-extension-for-pyrukynd-in-thalassemia 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/agios-pyrukynd-mitapivat-approved-for-thalassemia-in-saudi-arabia 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/akesos-ivonescimab-receives-breakthrough-therapy-designation-in-china-for-triple-negative-breast-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/aktiias-hilo-band-first-cuffless-blood-pressure-monitor-approved-for-otc-use-by-fda 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/alto-neuroscience-receives-fda-fast-track-designation-for-alto-101-for-cognitive-impairment-associated-with-schizophrenia 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/amneal-receives-fda-approval-for-prednisolone-acetate-ophthalmic-suspension 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/astrazeneca-launches-at-home-delivery-service-for-flumist-nasal-spray-vaccine 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/avenacy-launches-lidocaine-hydrochloride-injection-in-the-us 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/bicara-therapeutics-receives-fda-breakthrough-therapy-designation-for-ficerafusp-alfa-in-1l-hpv-negative-rm-hnscc 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/biocardia-announces-fda-and-pmda-regulatory-timeline-for-cardiamp-cell-therapy-and-helix-catheter 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/biocon-biologics-receives-fda-approval-for-denosumab-biosimilars-bosaya-and-aukelso 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/biogen-receives-complete-response-letter-from-fda-for-high-dose-nusinersen-in-spinal-muscular-atrophy 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/blenrep-combinations-approved-in-canada-for-relapsedrefractory-multiple-myeloma 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/boehringer-ingelheims-hernexeos-approved-in-china-for-her2-mutant-nsclc 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/c4-therapeutics-partner-biogen-receives-fda-ind-acceptance-for-irak4-degrader-biib142 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/caranx-medical-receives-fda-clearance-for-ai-powered-software-guiding-transcatheter-heart-valve-implantation 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/cellectar-biosciences-announces-ema-eligibility-for-conditional-marketing-authorization-of-iopofosine-i-131-for-refractory-waldenstrom-macroglobulinemia 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/china-approves-hutchmeds-orpathys-and-tagrisso-combination-for-lung-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/cingulates-ctx-1301-for-adhd-fda-alignment-on-nda-filing 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/civica-to-launch-affordable-long-acting-insulin-glargine-in-the-us 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/corcept-submits-nda-for-relacorilant-in-platinum-resistant-ovarian-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/dupixent-approved-for-bullous-pemphigoid 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/dupixent-approved-for-bullous-pemphigoid-14a36 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/dyne-therapeutics-dyne-251-receives-fda-breakthrough-therapy-designation-for-duchenne-muscular-dystrophy 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/dyne-therapeutics-receives-fda-breakthrough-therapy-designation-for-dyne-101-in-myotonic-dystrophy-type-1 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/echosens-and-novo-nordisk-partner-to-improve-mash-diagnosis-and-treatment 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/ema-lifts-restriction-on-valnevas-chikungunya-vaccine-ixchiq-for-elderly-patients 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/empnia-receives-fda-clearance-for-emotus-respiratory-motion-management-system 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/enhertu-receives-time-limited-reimbursement-in-canada-for-gastric-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-accepts-waiver-of-clinical-efficacy-studies-for-monoclonal-antibody-biosimilars 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-and-cdc-recommend-pause-in-ixchiq-use-for-elderly-individuals 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approval-of-keytruda-for-head-and-neck-cancer-highlights-potential-for-cel-scis-multikine-in-pd-l1-negative-patients 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-arcutis-zoryve-topical-foam-for-plaque-psoriasis 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-bildyos-and-bilprevda-biosimilars-to-prolia-and-xgeva 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-boehringer-ingelheims-jascayd-nerandomilast-for-idiopathic-pulmonary-fibrosis 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-genentechs-gazyva-for-lupus-nephritis-treatment 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-genentechs-susvimo-for-diabetic-retinopathy 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-ind-application-for-myrios-phox2b-pc-car-t-therapy-for-neuroblastoma 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-insightecs-exablate-neuro-for-staged-bilateral-treatment-of-parkinsons-disease 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-kerendia-finerenone-for-heart-failure-with-lvef-40 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-nucala-for-copd-expansion 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-papzimeos-for-recurrent-respiratory-papillomatosis 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-phraxis-endoforce-connector-for-dialysis-access 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-roches-susvimo-for-diabetic-retinopathy 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-updated-indication-for-winrevair-sotatercept-csrk-for-pulmonary-arterial-hypertension-based-on-phase-3-zenith-study 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-approves-wegovy-for-the-treatment-of-mash 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-clears-deepsights-needlevue-lc1-ultrasound-system 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-clears-united-imagings-uangio-aviva-interventional-x-ray-system 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-delays-sebetralstat-nda-decision-due-to-resource-constraints 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-grants-fast-track-designation-to-zeniths-zen-3694-for-nut-carcinoma 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-grants-orphan-drug-designation-to-jr-446-for-mucopolysaccharidosis-type-iiib 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-grants-orphan-drug-designation-to-klotho-neurosciences-klto-202-for-als 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-grants-priority-review-to-syndaxs-revuforj-revumenib-for-relapsedrefractory-mnpm1-aml 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-grants-rmat-designation-to-engenes-detalimogene-for-high-risk-bladder-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-rejects-ultragenyxs-gene-therapy-for-sanfilippo-syndrome-due-to-manufacturing-issues 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/fda-suspends-license-for-valnevas-chikungunya-vaccine-ixchiq 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/innocares-mesutoclax-receives-breakthrough-therapy-designation-in-china 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/innovents-mazdutide-approved-in-china-for-glycemic-control-in-type-2-diabetes 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/ipsens-cabometyx-receives-positive-chmp-opinion-for-advanced-neuroendocrine-tumors 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/kedrion-biopharma-receives-fda-approval-for-qivigy-for-primary-humoral-immunodeficiency 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/krystal-biotechs-vyjuvek-approved-in-japan-for-dystrophic-epidermolysis-bullosa 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/labcorp-launches-first-fda-cleared-blood-test-for-alzheimers-disease 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/madrigal-receives-positive-chmp-opinion-for-resmetirom-rezdiffra-for-mash 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/mannkind-announces-fda-acceptance-of-sbla-for-afrezza-in-pediatric-diabetes-patients 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/median-technologies-submits-510k-application-for-eyonis-lcs-lung-cancer-screening-samd 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/modernas-rsv-vaccine-mresvia-receives-fda-approval-for-expanded-use-in-adults-aged-18-59 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/neuspera-medical-receives-fda-approval-for-integrated-sacral-neuromodulation-isnm-system-for-urinary-urge-incontinence 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/noul-receives-fda-registration-for-cervical-cancer-diagnostic-cartridge 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/novartis-receives-approval-for-first-malaria-medicine-for-newborns-and-young-infants 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/olomorasib-receives-fda-breakthrough-therapy-designation-for-kras-g12c-mutant-lung-cancer 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/os-therapies-receives-fda-and-mhra-feedback-on-ost-her2-for-metastatic-osteosarcoma 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/palisade-bio-receives-canadian-patent-for-pali-2108-composition 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/positive-chmp-opinion-for-decipheras-vimseltinib-in-treating-tenosynovial-giant-cell-tumor 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/positive-chmp-opinion-for-tevimbra-in-neoadjuvantadjuvant-nsclc-treatment 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/prokidney-announces-fda-alignment-on-accelerated-approval-pathway-for-rilparencel 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/protagonist-submits-nda-for-icotrokinra-a-novel-oral-treatment-for-plaque-psoriasis 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/quralis-licenses-novel-mechanism-for-fragile-x-syndrome-treatment 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/relief-therapeutics-rlf-td011-denied-qidp-designation-but-remains-on-track-for-eb-treatment 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/sanofis-sar446523-receives-orphan-drug-designation-for-multiple-myeloma 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/saol-therapeutics-receives-fda-complete-response-letter-for-sl1009-dca-for-pyruvate-dehydrogenase-complex-deficiency 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/saptalis-pharmaceuticals-launches-likmez-first-fda-approved-ready-to-use-metronidazole-oral-suspension 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/shanton-pharmas-sap-001-receives-fda-fast-track-designation-for-refractory-gout 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/shorla-oncologys-sh-110-receives-fda-orphan-drug-designation-for-glioma 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/soleno-therapeutics-presents-vykat-xr-data-at-ispor-2025-for-prader-willi-syndrome 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/spruce-biosciences-receives-fda-breakthrough-therapy-designation-for-tralesinidase-alfa-for-sanfilippo-syndrome-type-b 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/sun-pharma-launches-leqselvi-deuruxolitinib-for-severe-alopecia-areata-in-the-us 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/terumo-neuro-launches-sofia-88-neurovascular-support-catheter-in-the-us 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/test-pr 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/teva-launches-first-generic-glp-1-for-weight-loss-liraglutide-injection 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/trinity-biotech-receives-regulatory-approval-for-preclara-preeclampsia-test 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/vanda-pharmaceuticals-announces-collaborative-framework-with-fda-for-dispute-resolution 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/vanda-pharmaceuticals-vgt-1849b-receives-orphan-drug-designation-for-polycythemia-vera 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/vertex-pharmaceuticals-wins-innovation-award-for-journavx-a-novel-non-opioid-acute-pain-treatment 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/viridian-therapeutics-veligrotug-receives-fda-breakthrough-therapy-designation-for-thyroid-eye-disease 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/vizient-applauds-fda-actions-to-accelerate-biosimilar-development-and-lower-costs 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/zemcelpro-receives-positive-chmp-opinion-for-blood-cancer-treatment 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/publication-reports/zevra-therapeutics-announces-presentations-on-miplyffa-arimoclomol-at-niemann-pick-disease-conference 2026-04-06T14:24:08.385Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/23andme-sold-to-ttam-research-institute-for-305-million 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/abbvie-acquires-capstan-therapeutics-and-its-novel-car-t-therapy-candidate 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/abbvie-acquires-gilgamesh-pharmaceuticals-bretisilocin-for-major-depressive-disorder 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/adaptimmune-sells-cell-therapies-to-us-worldmeds-for-55-million 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/aleracare-and-pure-healthcare-to-merge-creating-a-leading-ambulatory-infusion-platform 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/biocon-biologics-and-civica-expand-partnership-to-launch-insulin-glargine-for-us-diabetes-patients 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/biofrontera-inc-acquires-us-rights-to-ameluz-and-rhodoled-secures-11-million-investment 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/biontech-to-acquire-curevac-in-125-billion-all-stock-acquisition 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/boehringer-ingelheim-and-aimedbio-collaborate-to-advance-novel-adc-therapy-for-broad-range-of-cancers 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/cantargia-licenses-can10-il1rap-immunology-program-to-otsuka-pharmaceutical 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/carlyle-and-sk-capital-complete-acquisition-of-bluebird-bio 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/chugai-and-gero-partner-to-develop-novel-therapies-for-age-related-diseases 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/cormedix-to-acquire-melinta-therapeutics-expanding-its-specialty-pharmaceutical-portfolio 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/crispr-and-sirius-therapeutics-partner-to-develop-sirna-therapies-for-thromboembolic-disorders 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/demetra-acquires-orthofundamentals-and-launches-global-spine-division 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/elutia-closes-bioenvelope-business-sale-to-boston-scientific-for-88-million-focuses-on-nxt-41x-for-breast-reconstruction-infections 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/enchannel-medical-acquires-acutus-medicals-acqmap-electrophysiology-assets 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/fujirebio-acquires-plasma-services-group-strengthening-its-biomaterials-supply 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/gate-bioscience-and-lilly-partner-to-develop-molecular-gate-medicines 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/hengrui-pharma-and-gsk-partner-to-develop-up-to-12-innovative-medicines 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/innovent-and-takeda-partner-to-develop-next-gen-io-and-adc-therapies 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/lakeshore-biopharma-receives-revised-acquisition-proposal 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/ligand-completes-merger-with-channel-therapeutics-launching-zelsuvmi-for-molluscum-contagiosum 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/mallinckrodt-and-endo-merger-creates-global-therapeutics-leader 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/maxcyte-and-moonlight-bio-partner-to-advance-t-cell-therapies-for-solid-tumors 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/medtronic-announces-minimed-as-name-for-planned-new-diabetes-company 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/melinta-therapeutics-acquired-by-cormedix-for-300-million 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/merck-acquires-verona-pharma-for-10-billion-expanding-copd-treatment-portfolio 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/novartis-acquires-tourmaline-bio-for-14-billion-expanding-cardiovascular-pipeline-with-pacibekitug 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/novartis-to-acquire-avidity-biosciences-for-12-billion 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/novo-nordisk-to-acquire-akero-therapeutics-for-up-to-52-billion 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/pierre-fabre-laboratories-acquires-worldwide-rights-for-pfl-721-and-pfl-241-expanding-its-oncology-portfolio 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/polpharma-biologics-and-ms-pharma-partner-to-commercialize-biosimilars-in-mena 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/quell-therapeutics-and-astrazeneca-advance-car-treg-cell-therapy-for-inflammatory-bowel-disease 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/repare-therapeutics-out-licenses-discovery-platforms-to-dcx-biotherapeutics 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/repare-therapeutics-outlicenses-lunresertib-to-debiopharm 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/roche-to-acquire-89bio-for-mash-therapy-development 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/rybodyn-joins-lilly-gateway-labs-to-advance-next-gen-immunotherapies 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/sanofi-acquires-rights-to-arrowheads-plozasiran-for-hypertriglyceridemia-in-greater-china 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/sanofi-acquires-vigil-neuroscience-to-expand-alzheimers-disease-pipeline 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/sartorius-stedim-biotech-and-sensible-biotechnologies-partner-to-scale-up-mrna-manufacturing 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/servier-and-ideaya-biosciences-partner-to-develop-darovasertib-for-uveal-melanoma 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/thermo-fisher-and-sanofi-expand-partnership-acquisition-of-sterile-drug-manufacturing-site 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/clinical-trial-outcomes/zydus-and-synthon-partner-for-ozanimod-capsules-in-the-us-market 2026-04-06T14:24:08.386Z weekly 0.8 https://pienomial.com/blog/ai-accuracy-vs-ai-hallucinations-what-pharma-teams-must-know-before-deploying-ai-solutions 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/beyond-the-spreadsheet-how-multimodal-ai-is-merging-trial-data-genomics-and-real-world-evidence-to-predict-study-success 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/clinical-trial-planning-mistakes-pharma-teams-must-avoid-in-2026 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/connected-strategy-bridging-trial-design-to-regulatory-success-with-evidence-intelligence 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/digital-twins-in-clinical-trials-how-ai-generated-virtual-control-arms-are-rewriting-study-design-in-2026 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/federated-learning-in-pharma-how-10-competing-companies-built-a-shared-ai-model-without-sharing-a-single-data-point 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/how-ai-competitive-intelligence-creates-a-3-month-to-1-year-strategic-edge 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/how-ai-is-reshaping-drug-development-and-regulatory-planning 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/how-an-ai-research-assistant-simplifies-evidence-review-across-life-sciences-teams 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/how-evidence-intelligence-platforms-are-transforming-clinical-trial-strategy 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/how-real-time-insights-accelerate-market-access-decisions-for-life-sciences 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/how-scenario-mapping-helps-life-sciences-teams-make-better-strategic-decisions 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/how-trial-lens-supports-faster-clinical-trial-analysis-and-planning 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/how-trusted-ai-is-transforming-evidence-generation-for-pharma-heor-teams 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/hta-ready-evidence-before-phase-3-trials 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/living-protocols-how-machine-readable-trial-design-powered-by-historical-data-is-eliminating-protocol-amendments 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/pharma-teams-unified-platforms 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/research-assistants-heor-clinical-teams 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/seeing-the-whole-board-how-ci-lens-powers-competitive-strategy-in-drug-development 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/the-fdas-7-step-ai-credibility-framework-why-regulatory-grade-trial-data-is-pharmas-next-competitive-moat 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/what-makes-a-systematic-literature-review-truly-audit-ready 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/what-makes-an-ai-powered-systematic-literature-review-more-reliable 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/what-makes-an-ai-system-reliable-enough-for-life-sciences-decision-making 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/where-real-time-evidence-insights-drive-market-access-success 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/why-competitive-intelligence-is-reshaping-clinical-strategy-in-pharma 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/why-competitive-intelligence-should-start-before-trial-design 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/why-compliance-ready-ai-is-the-future-of-pharma-evidence-hta-and-market-access 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/why-evidence-traceability-matters-in-ai-powered-literature-reviews-and-hta-submissions 2026-04-06T14:24:08.433Z weekly 0.7 https://pienomial.com/blog/why-unified-data-platforms-are-the-future-of-evidence-in-life-sciences 2026-04-06T14:24:08.433Z weekly 0.7